MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2023-24)
- Udyam number
- UDYAM-TS-25-0000320
Rampex Labs Private Limited - pharma in Bollaram Villege, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹152.68 Cr
▲ 16% YoY
Net profit · FY 2025
₹9.69 Cr
Net margin 6.3%
EBITDA · FY 2025
₹21.4 Cr
EBITDA margin 14%
Authorised capital
₹35 Cr
Registered with MCA
Paid-up capital
₹26.69 Cr
Issued & subscribed
Open charges
₹68.66 Cr
Satisfied ₹69.11 Cr
Company age
22 yrs
Est. 2004
Employees · EPFO
322
Provident fund records
About Rampex Labs Private Limited
Data last updated:
Rampex Labs Private Limited is a private limited company based in Bollaram Villege, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 18 May 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2004PTC043271. Its GSTIN is 36AACCR7394H1ZZ (Telangana). The company holds 3 GST registrations, all of them active.
The company has an authorised share capital of ₹35 Cr and a paid-up capital of ₹26.69 Cr. It is led by directors including Venkateswara Rao Ghattamaneni (Whole-Time Director) and Surya Venkata Narasimha Sastry Jayanty (Whole-Time Director).
Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.151 S.V.Cooperative Industrial Estate Bollaram Villege Jinnaram Mandal, Telangana, India – 502325.
As per the financials filed for FY 2025, the company reported a revenue of ₹152.68 Cr, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹9.69 Cr (net margin 6.3%) and EBITDA of ₹21.4 Cr (EBITDA margin 14%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 5% over five years.
The company has about 322 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Rampex Labs. As per MCA filings, the company has open charges of ₹68.66 Cr and satisfied charges of ₹69.11 Cr on record. Court records list 10 cases involving the company, including 3 filed by the company and 7 filed against it; 2 cases are pending. The company has 22 deals on record (13 secondary share transfers, 6 funding rounds, 3 rights issues), with disclosed funding of ₹37.07 Cr; the latest was in March 2023. Its 8 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 4 smaller; the largest is Everest Organics Limited with revenue of ₹160.17 Cr. The company has 14 MSME Form 1 returns on record between 2019 and 2024, listing 1,598 overdue payments to 140 micro and small suppliers.
Rampex Labs Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-25-0000320). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website rampexlabs.com.
Company details
CIN U24239TG2004PTC043271
Registration Number 043271
Incorporation Date 18 May 2004
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 26 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-TS-25-0000320
CIN history
Rampex Labs has one previous CIN (Corporate Identification Number): U24239AP2004PTC043271. The current CIN is U24239TG2004PTC043271, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2004PTC043271 | Current |
| U24239AP2004PTC043271 | Previous |
Key People
Venkateswara Rao Ghattamaneni Whole-Time Director Surya Venkata Narasimha Sastry Jayanty Whole-Time Director Jatinbhai Siddharthbhai Shah Director Recognitions & Rankings of Rampex Labs
Contact details
Rampex Labs Private Limited's registered office is in Bollaram Villege, Telangana. Its website is rampexlabs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No.151 S.V.Cooperative Industrial Estate Bollaram Villege Jinnaram Mandal, Telangana, India – 502325
- IndustryPharma, API Manufacturers
To see the full contact details of Rampex Labs Private Limited, buy the company report.
Comprehensive company report
Rampex Labs Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Rampex Labs operates one associated brand: Rampex Labs. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical intermediates for APIs are manufactured by Rampex Labs. | rampexlabs.com |
Business activity
The main business activity of Rampex Labs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Rampex Labs Private Limited, buy the company report.
Financials of Rampex Labs Private Limited
FY 2025 filings availableRampex Labs Private Limited reported revenue of ₹152.68 Cr (up 16% YoY) for FY 2025.
Revenue · FY 2025
₹152.68 Cr ▲ 16%
Net profit · FY 2025
₹9.69 Cr margin 6.3%
EBITDA · FY 2025
₹21.4 Cr margin 14%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 16%
3 years · compounded
▼ 1%
5 years · compounded
▲ 5%
EBITDA CAGR growth
1 year
▲ 22%
3 years · compounded
▲ 11%
5 years · compounded
▲ 20%
Revenue has grown at a compounded annual rate (CAGR) of 5% over five years, including 16% growth in the latest year. EBITDA rose 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹21.4 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹9.69 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14% | ||||
| Net Profit Margin | 6.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Rampex Labs Private Limited, buy the company report.
Board of directors of Rampex Labs Private Limited
Rampex Labs has 7 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jatinbhai Siddharthbhai Shah | Director | 02 Sep 2021 | 5 Years 1 Months | Current |
| Venkateswara Rao Ghattamaneni | Whole-Time Director | 29 Sep 2022 | 4 Years 0 Months | Current |
| Surya Venkata Narasimha Sastry Jayanty | Whole-Time Director | 01 Apr 2008 | 18 Years 6 Months | Current |
| Nishant Tiwary Also directs: South Atlantic Partners India Private Limited | Director | 01 Jul 2024 | 2 Years 3 Months | Current |
| Maganti Murali Also directs: KBM Properties LLP, Vani Plastics & Plantations Private Limited, Krishna Poly Packs Pvt Ltd and 3 more | Director | 07 Oct 2004 | 22 Years 0 Months | Current |
| Lokanath Bolleni Also directs: Tukaram & Co LLP | Director | 07 Oct 2004 | 22 Years 0 Months | Current |
Showing 6 of 7 current directors. View all directors
Peer comparison
Rampex Labs Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Everest Organics Limited | ₹160.17 Cr (FY 2025) | -19.0% | Medak, Telangana, India | |||
| Infinium Pharmachem Limited | ₹157.83 Cr (FY 2025) | 15.0% | Sojitra, Gujarat, India | |||
| Gujarat Themis Biosyn Ltd | ₹153.23 Cr (FY 2025) | -12.0% | Valsad, Gujarat, India | |||
| Allchem Lifescience Limited | ₹152.78 Cr (FY 2025) | 11.0% | Vadodara, Gujarat, India | |||
| Rampex Labs Private Limitedthis company | ₹152.68 Cr (FY 2025) | ₹9.69 Cr | 6.3% | 16.0% | 322 | Bollaram Villege, Telangana, India |
| SPC Life Sciences Limited | ₹151.89 Cr (FY 2025) | -3.0% | Vadodara, Gujarat, India | |||
| Therapiva Private Limited | ₹148.94 Cr (FY 2021) | -23.0% | Secunderabad, Telangana, India | |||
| Unimark Remedies Limited | ₹148.77 Cr (FY 2018) | -19.0% | Mumbai, Maharashtra, India | |||
| Atlas Life Sciences Private Limited | ₹148.18 Cr (FY 2022) | 35.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Rampex Labs Private Limited, buy the company report.
Shareholding
The shareholding of Rampex Labs Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Rampex Labs Private Limited, buy the company report.
Charges & borrowings
Open charges
₹68.66 Cr
Satisfied charges
₹69.11 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Aug 2019 | 100286123 | Hdfc Bank Limited | ₹57.52 Cr | Open | |
| 16 Feb 2019 | 100253588 | The South Indian Bank Limited | ₹11.14 Cr | Open | |
| 01 Aug 2016 | 100042711 | Others | ₹4 Cr | Satisfied | |
| 02 Apr 2007 | 10047822 | Others | ₹63.36 Cr | Satisfied | |
| 12 Mar 2007 | 10044703 | Industrial Development Bank of India | ₹1.75 Cr | Satisfied |
To see the full charge records of Rampex Labs Private Limited, buy the company report.
Total charge records: 5 View all charges
Deals & funding
Rampex Labs Private Limited has 22 deals on record (13 secondary share transfers, 6 funding rounds, 3 rights issues), with disclosed funding of ₹37.07 Cr; the latest was in March 2023.
Total deals
22
Secondary share transfers
13
Funding rounds
6
Rights issues
3
Disclosed funding
₹37.07 Cr
Deals on record (5 of 22)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2023 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: Vinatarita Agro Private Limited , 3 individuals |
| Oct 2022 | Rights issue | ₹6.07 Cr | Investors: Krishna Poly Packs Pvt Ltd , 3 individuals |
| May 2018 | Funding round | ₹14.06 Cr | Investors: 4 individuals |
| Mar 2018 | Secondary share transfer | Undisclosed | Buyer: Vinatarita Agro Private Limited , an individual Seller: Ranga Nb Gorrepati Charitable Lead Trust, K V Chaoudary HUF, an individual |
| Apr 2017 | Rights issue | ₹6.87 Cr | Investors: Espee Lifesciences Private Limited , an individual |
To see the full deal history of Rampex Labs Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Rampex Labs Private Limited has 10 court cases on record: 3 filed by Rampex Labs, 7 filed against it. 2 cases are pending and 8 are disposed.
Total cases
10
Filed by the company
3
Filed against the company
7
Pending
2
Disposed
8
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 7 | 5 | 0 |
| High courts | 3 | 2 | 2 |
Cases on record (5 of 10)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, TELANGANA | Court case (MACMA) | Filed against the company by United India Insurance Co. Ltd | Pending |
| High Court, ANDHRAPRADESH | Writ petition | Filed by the company against Eastern Power Distribution Company of Andhra Pradesh Ltd., and 1 other | Disposed |
| District court, Hyderabad CCC, Telangana | Appeal | Filed against the company by Sharon Bio Medicine Ltd., Rep. by Its Authorized Signatory Sanjeev Suryavamshi | Disposed |
| District court, Hyderabad CCC, Telangana | Criminal complaint | Filed by the company against Sharon Bio Medicine Ltd | Disposed |
| District court, Hyderabad CCC, Telangana | Criminal complaint | Filed by the company against Ms Vensa Laboratories Pvt Ltd and 1 other | Disposed |
To see the full case history of Rampex Labs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Rampex Labs Private Limited has 14 MSME Form 1 returns on record between 2019 and 2024, listing 1,598 overdue payments to 140 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 140)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Lab Needs Private Limited | |||
| an individual supplier | |||
| an individual supplier | |||
| Ladder Fine Chemicals | |||
| Sanjay Chemicals (India) Private Limited |
To see the full MSME payment records of Rampex Labs Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Rampex Labs Private Limited has a workforce of 322 employees on its EPFO records as of Apr 02, 2024, across 1 active EPFO establishment.
Employee count
322
Active EPFO establishments
1
Employee growth
-2.72%
GST
Rampex Labs has 3 GST registrations: 3 active.
Total GSTINs
3
Active
3
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AACCR7394H1ZZ | Telangana | Active | 01 Jul 2017 |
| 36AACCR7394H2ZY | Telangana | Active | 01 Jun 2020 |
| 37AACCR7394H1ZX | Andhra Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Rampex Labs Private Limited, buy the company report.
Recent activity
Rampex Labs Private Limited has 15 board changes on record since 2004: 7 appointments and 8 cessations. The latest: Nishant Tiwary ceased to be Additional Director on 18 Sep 2024.
AGM
Rampex Labs Private Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records.
Filing
Rampex Labs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Nishant Tiwary ceased to be Additional Director.
Appointed
Nishant Tiwary was appointed as Director.
Charges
A charge with Hdfc Bank Limited of Rs. 57.52 Cr registered on 28 Aug 2019 with Charge ID 100286123 was modified on 19 Jun 2024.
Appointed
Venkateswara Rao Ghattamaneni was appointed as Whole-Time Director.
Charges
A charge with The South Indian Bank Limited of Rs. 11.14 Cr registered on 16 Feb 2019 with Charge ID 100253588 was modified on 20 Sep 2022.
Ceased
Chemuduri Prasanth ceased to be Whole-Time Director.
Ceased
Jatinbhai Siddharthbhai Shah ceased to be Additional Director.
Appointed
Jatinbhai Siddharthbhai Shah was appointed as Director.
Charges
A charge registered on 02 Apr 2007 via Charge ID 10047822 with Others was fully satisfied on 18 Oct 2019.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 57.52 Cr with Charge ID 100286123 was registered on 28 Aug 2019.
18 earlier events are in the company report.
Frequently asked questions
Rampex Labs is an active private limited company based in Bollaram Villege, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 18 May 2004 (22+ years old) and is registered under CIN U24239TG2004PTC043271.
Rampex Labs has 7 current directors:
- Venkateswara Rao Ghattamaneni - Whole-Time Director
- Surya Venkata Narasimha Sastry Jayanty - Whole-Time Director
- Jatinbhai Siddharthbhai Shah - Director
- Nishant Tiwary - Director
- Maganti Murali - Director
- Lokanath Bolleni - Director
- Gorrepati Ranga N B - Director
The latest financial statements of Rampex Labs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 26 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Rampex Labs is 36AACCR7394H1ZZ, registered in Telangana. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 36AACCR7394H2ZY (Telangana), 37AACCR7394H1ZX (Andhra Pradesh).
The CIN (Corporate Identification Number) of Rampex Labs is U24239TG2004PTC043271. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rampex Labs has 10 court cases on record: 3 filed by the company and 7 filed against it. 2 are pending. Most are in the district courts.
Rampex Labs was incorporated on 18 May 2004, making it 22+ years old. It is registered with the Registrar of Companies, Hyderabad.
Rampex Labs has 22 deals on record (13 secondary share transfers, 6 funding rounds, 3 rights issues), with disclosed funding of ₹37.07 Cr; the latest was in March 2023.
The peers of Rampex Labs by revenue are Everest Organics Limited, Infinium Pharmachem Limited, Gujarat Themis Biosyn Ltd, Allchem Lifescience Limited, SPC Life Sciences Limited and 3 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Nishant Tiwary ceased to be Additional Director on 18 Sep 2024. Nishant Tiwary was appointed as Director on 01 Jul 2024. Venkateswara Rao Ghattamaneni was appointed as Whole-Time Director on 29 Sep 2022. Rampex Labs has 15 board changes on record in total.
Yes, Rampex Labs is registered as a medium enterprise under Udyam registration (number: UDYAM-TS-25-0000320).
Rampex Labs has 14 MSME Form 1 returns on record between 2019 and 2024, listing 1,598 overdue payments to 140 micro and small suppliers. The latest return was filed on 18 Apr 2024.